Facebook Pixel Code
About Sickkids
About SickKids

William Logan, MD, FRCP(C)

The Hospital for Sick Children
Senior Staff Neurologist
Neurology

University of Toronto
Professor
Departments of Medicine & Paediatrics


Phone: 416-813-6660
Fax: 416-813-6334
Email: william.logan@sickkids.ca

Brief Biography

Dr. Logan is a Professor of Paediatrics in the Faculty of Medicine, University of Toronto and a Senior Neurologist at SickKids. He is also a consulting neurologist at the Bloorview MacMillan Children’s Centre, Women’s & Sunnybrook Health Sciences Centre and the Centre For Addiction and Mental Health.

Dr. Logan was trained in Medicine a the University of Chicago School of Medicine. He received paediatric training at the Johns Hopkins Hospital and the Cincinnati Children’s Hospital. Dr. Logan’s neurology training was at the Stanford University School of Medicine and Medical Center at the Johns Hopkins Hospital. He spent two years as clinical/associate (NICHD/NIDR) and Senior Assistant Surgeon, USPHS at the National Institutes of Health.

Following a neuropharmacology fellowship at the Johns Hopkins University School of Medicine, he joined the Departments of Neurology and Pediatrics at the University of Virginia School of Medicine as Director of Pediatric Neurology. He then became Head, Division of Neurology at SickKids in the Department of Paediatrics, University of Toronto. After completing his third term as Division Head, he took a sabbatical year at the Massachusetts General Hospital as Visiting Professor of Neurology at the Harvard Medical School and then returned to his present position. Dr. Logan is currently a member of the Executive Board of the International Child Neurology Association, a regional editor of the International Review of Child Neurology series, and is chief editor of the Association’s web-based knowledge environment, ICNApedia.org.

He previously was Secretary General of the International Child Neurology Society, Chairman of the Royal College Nucleus Committee on Neurology, President of the Canadian Association of Child Neurology and member of the Executive Board of the American Child Neurology Society.

At present in the Division of Neurology, Dr. Logan specializes in movement disorders, functional MRI and cerebrovascular reactivity studies.

Areas of Specialty:

Motor disorders, functional imaging.


Clinical Care Activities

Movement disorders, functional MRI, cerebrovascular reactivity assessment

Academic Background

Fellowship, Neuropharmacology
The Johns Hopkins School of Medicine, Baltimore, MD

Clinical/Research Associate, Public Health Service
National Institute of Child Health & Human Development, Bethesda, MD

Research Interests

  • functional MRI assessment of cerebrovascular reserve
  • development of functional MRI language activationparadigms for use in children
  • differences of brain activation in the developing and mature brain

Research Activities

functional MRI assessment of cerebrovascular reserve, development of functional MRI language activation paradigms for use in children

Future Research Interests

Plasticity in the developing brain.

Achievements

Special Traineeship Award. 2F11 NS-1974. National Institutes of Health. 1969 - 1972. 1969

Publications


Fernandes MA, Smith ML, Logan W, Crawley A, McAndrews MP: Comparing language lateralization determined by dichotic listening and fMRI activation in frontal and temporal lobes in children with epilepsy. Brain and Language 2006. 96: pp 106-114.

Benifla M, Rutka JT, Logan W, Donner EJ: Vagal nerve stimulation for refactory epilepsy in children: indications and experience at The Hospital for Sick Children. Childs Nervous System 2006. 22: pp 1018-1026.

Rubinstein S, Malone MA, Roberts W, Logan WJ: Placebo-Controlled Study Examining Effects of Selegiline in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 2006. 16: pp 404-415.

Kadis D S, Iida K, Kerr EN, Logan W J, McAndrews MP, Ochi A, Otsubo H, Rutka JT, Snead OC III, Weiss SK, Smith ML. Intrahemispheric reorganization of language in children with medically intractable epilepsy of the left hemisphere. Journal of the International Neuropsychological Society 2007. 13: pp 505-516.

Buncic JR. Westall CA. Panton CM. Munn JR. MacKeen LD. Logan WJ. Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children. Ophthalmology. 2004, 111(10):1935-42.

Hamoudi, D.S, Lee, S.S.F., Madison, A., Mirabella, G., Buncic,J.R., Logan, W.J., Snead, O.C. Westall, C.A. Reduced vision function associated with infantile spasms in children on vigabatrin therapy. Investigative Ophthalmology and Visual Science. 2005, 46(2): 514-520.

Mikulis, D. J., Krolczyk, G., Desai, H., Logan, W., DeVeber, G., Dirks, P., Tymianski, M., Crawley, A., Vesely, A., Kassner, A., Preiss, D., Somogyi, R., Fisher, J. A. Preoperative and postoperative mapping of cerebrovascular reactivity in moyamoya disease by using blood oxygen level-dependent magnetic resonance imaging. Journal of Neurosurgery. 2005, 103:347-355.